Stockscreener 앱 받기
2.04
7.69%
-0.17
시간 외 거래:
2.00
-0.04
-1.96%
전일 마감가:
$2.21
열려 있는:
$2.16
하루 거래량:
48,863
Relative Volume:
0.30
시가총액:
$2.09M
수익:
-
순이익/손실:
$-11.27M
주가수익비율:
-0.0953
EPS:
-21.4132
순현금흐름:
$-9.40M
1주 성능:
-12.07%
1개월 성능:
-21.54%
6개월 성능:
-67.72%
1년 성능:
-83.41%
1일 변동 폭
$1.965
$2.25
1주일 범위
$1.965
$2.4199
52주 변동 폭
$1.965
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
명칭
Dermata Therapeutics Inc
전화
(858)-223-0882
주소
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
DRMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
2.04 | 2.27M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.21 | 116.79B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.17 | 81.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.70 | 53.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
845.95 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.77 | 37.48B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dermata Therapeutics Inc 주식(DRMA)의 최신 뉴스
Can Dermata Therapeutics Inc. Equity Warrant stock deliver consistent earnings growthTrade Volume Report & Smart Money Movement Alerts - Улправда
Will Dermata Therapeutics Inc. stock reach all time highs in 20252025 Trading Volume Trends & Stock Portfolio Risk Management - Улправда
How buybacks impact Dermata Therapeutics Inc. stock valueLayoff News & Community Supported Trade Ideas - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock could rally in 2025Quarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Intraday Action & Stock Portfolio Risk Control - Улправда
Will Dermata Therapeutics Inc. stock split again soonJuly 2025 Macro Moves & Precise Swing Trade Alerts - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock is popular among millennialsTake Profit & Weekly Watchlist for Hot Stocks - DonanımHaber
Will Dermata Therapeutics Inc. stock outperform growth indexesWeekly Trade Review & Expert Curated Trade Setups - DonanımHaber
Why Dermata Therapeutics Inc. Equity Warrant stock remains undervaluedCEO Change & Weekly High Potential Alerts - Bölüm Sonu Canavarı
Will Dermata Therapeutics Inc. stock attract more institutional investorsJuly 2025 Momentum & Comprehensive Market Scan Reports - DonanımHaber
Growth Value: Will Dermata Therapeutics Inc. Equity Warrant stock gain from lower inflation2025 Macro Impact & Low Volatility Stock Recommendations - DonanımHaber
Support Test: Will Dermata Therapeutics Inc. stock deliver shareholder valueJuly 2025 Gainers & Accurate Intraday Trading Signals - DonanımHaber
Is Dermata Therapeutics Inc. stock vulnerable to regulatory risksGDP Growth & Daily Growth Stock Investment Tips - ulpravda.ru
Dermata Therapeutics Earnings Notes - Trefis
Total debt of Dermata Therapeutics Inc Warrant 2021- on Dermata Therapeutics – BOATS:DRMAW - TradingView — Track All Markets
Check Out Dermata Therapeutics Inc (DRMA)’s Trade Data Rather Than the Analysts’ Views - setenews.com
Aug Weekly: What technical signals suggest for IKNA stockMarket Risk Report & Scalable Portfolio Growth Methods - BỘ NỘI VỤ
Dermata Therapeutics, Inc. (DRMA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is Dermata Therapeutics Inc. Equity Warrant stock a buy on dipsBreakout Watch & Risk Adjusted Swing Trade Ideas - Newser
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
DRMAWDermata Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity - ACCESS Newswire
Is Dermata Therapeutics Inc Equity Warrant a good long term investmentVolatility Trading Techniques & Stay Ahead With Daily Market Discussions - earlytimes.in
Dermata Therapeutics (DRMA) Stock Analysis Report | Financials & Insights - Benzinga
Returns Recap: Will Dermata Therapeutics Inc. stock see insider buyingWeekly Trade Review & Detailed Earnings Play Strategies - moha.gov.vn
Dermata Therapeutics Inc files for mixed shelf of up to $100 million - marketscreener.com
Dermata Therapeutics, Inc.Warrant (NQ: DRMAW - Markets Financial Content
What momentum indicators show for Dermata Therapeutics Inc. Equity Warrant stockStock Surge & Real-Time Market Sentiment Alerts - newser.com
Can Dermata Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Snapshot & Stepwise Entry/Exit Trade Alerts - newser.com
Dermata Therapeutics Ends License Agreement with Villani - MSN
Can Dermata Therapeutics Inc. Equity Warrant stock sustain market leadershipTrend Reversal & Trade Opportunity Analysis - newser.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Statistical indicators supporting Dermata Therapeutics Inc.’s strengthEarnings Overview Summary & Real-Time Market Sentiment Reports - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock a safe investment in uncertain marketsWeekly Trading Summary & Weekly High Potential Stock Alerts - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock vulnerable to regulatory risksJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Why Dermata Therapeutics Inc. stock could see breakout soonWeekly Investment Summary & Stock Market Timing Techniques - newser.com
Can Dermata Therapeutics Inc. stock sustain market leadershipJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
How to manage a losing position in Dermata Therapeutics Inc.July 2025 Market Mood & Weekly Setup with High ROI Potential - newser.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Will Dermata Therapeutics Inc. stock benefit from green energy trendsQuarterly Profit Review & Low Drawdown Investment Ideas - newser.com
How to use Fibonacci retracement on Dermata Therapeutics Inc.Dollar Strength & Real-Time Buy Signal Alerts - newser.com
Can Dermata Therapeutics Inc. Equity Warrant stock resist market sell offsJuly 2025 Price Swings & Breakout Confirmation Alerts - newser.com
Is Dermata Therapeutics Inc. Equity Warrant building a consolidation base2025 Fundamental Recap & Short-Term High Return Strategies - newser.com
Has Dermata Therapeutics Inc. formed a bullish divergenceMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
Dermata Therapeutics Inc (DRMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.30%
자본화:
|
볼륨(24시간):